| A ribose-functionalized NAD+ with unexpected high activity and selectivity for protein poly-ADP-ribosylation XN Zhang, Q Cheng, J Chen, AT Lam, Y Lu, Z Dai, H Pei, NM Evdokimov, ... Nature communications 10 (1), 4196, 2019 | 32 | 2019 |
| Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes Q Cheng, Z Dai, G Smbatyan, AL Epstein, HJ Lenz, Y Zhang Molecular Therapy 30 (9), 3066-3077, 2022 | 27 | 2022 |
| Synthesis of site-specific antibody-drug conjugates by ADP-ribosyl cyclases Z Dai, XN Zhang, F Nasertorabi, Q Cheng, J Li, BB Katz, G Smbatyan, ... Science Advances 6 (23), eaba6752, 2020 | 26 | 2020 |
| Facile chemoenzymatic synthesis of a novel stable mimic of NAD+ Z Dai, XN Zhang, F Nasertorabi, Q Cheng, H Pei, SG Louie, RC Stevens, ... Chemical science 9 (44), 8337-8342, 2018 | 19 | 2018 |
| Expanding the toolbox of exosome-based modulators of cell functions Q Cheng, Z Dai, X Shi, X Duan, Y Wang, T Hou, Y Zhang Biomaterials 277, 121129, 2021 | 15 | 2021 |
| Rational design of a humanized antibody inhibitor of cathepsin B Z Dai, Q Cheng, Y Zhang Biochemistry 59 (14), 1420-1427, 2020 | 14 | 2020 |
| A two-trick pony: lysosomal protease cathepsin B possesses surprising ligase activity TR Lambeth, Z Dai, Y Zhang, RR Julian RSC chemical biology 2 (2), 606-611, 2021 | 10 | 2021 |
| Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy Z Dai, XN Zhang, Q Cheng, F Fei, T Hou, J Li, A Abdolvahabi, J Watanabe, ... Journal of Controlled Release 336, 433-442, 2021 | 4 | 2021 |
| Rational design of humanized antibody inhibitors for cathepsin S PW Yu, G Kao, Z Dai, F Nasertorabi, Y Zhang Archives of Biochemistry and Biophysics 751, 109849, 2024 | 1 | 2024 |
| Chemoenzymatic Preparation of 4′‐Thioribose NAD+ XN Zhang, Z Dai, Q Cheng, Y Zhang Current protocols in nucleic acid chemistry 77 (1), e83, 2019 | 1 | 2019 |
| 4-thioribose NAD analogues and methods of synthesizing and using the same Y Zhang, Z Dai, XN Zhang US Patent 11,834,470, 2023 | | 2023 |
| Site-specific antibody-drug conjugates by ADP-ribosyl cyclases Y Zhang, Z Dai, XN Zhang US Patent 11,684,676, 2023 | | 2023 |
| Chemical Biology TR Lambeth, Z Dai, Y Zhang, RR Julian | | 2021 |
| Methods of constructing immunoglobulin fusion proteins inhibiting cathepsin b and compositions thereof Y Zhang, Z Dai US Patent App. 16/090,148, 2019 | | 2019 |
